Foghorn Therapeutics Inc. (NASDAQ: FHTX) reported Q1 EPS of ($0.30), $0.11 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $5.95 million versus the consensus estimate of $5.95 million.

For earnings history and earnings-related data on Foghorn Therapeutics Inc. (FHTX) click here.